Apolipoprotein E and glial fibrillary acidic protein are known biomarkers of AD as indicated above (29, 30); the first plays a role in early amyloidosis, cholesterol metabolism, and inflammatory response, and the latter is an established marker of glial-specific neuroinflammation. This evidence concerns the gene GFAP and amyloidosis.